Literature DB >> 1760243

Chromosome 11q13 abnormalities in human cancer.

G A Lammie1, G Peters.   

Abstract

Structural abnormalities affecting band q13 of chromosome 11 have been reported in a variety of human tumors, particularly multiple endocrine neoplasia type 1 (MEN1), certain low-grade B-cell neoplasms, and a significant subset of breast and squamous cell carcinomas. The perturbations of the region are also varied, ranging from allele loss and deletions to specific translocations and DNA amplification. Given their clinical relevance in classifying tumors and identifying patients at increased risk, it is important to locate and characterize the genes on which these aberrations impinge. Here we assess the candidate genes identified thus far and the evidence that implicates them in tumorigenesis.

Entities:  

Mesh:

Year:  1991        PMID: 1760243

Source DB:  PubMed          Journal:  Cancer Cells        ISSN: 1042-2196


  46 in total

Review 1.  Mouse chromosome 7.

Authors:  E M Rinchik; T Magnuson; B Holdener-Kenny; G Kelsey; A Bianchi; C J Conti; F Chartier; K A Brown; S D Brown; J Peters
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb.

Authors:  C Neuveut; K G Low; F Maldarelli; I Schmitt; F Majone; R Grassmann; K T Jeang
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

3.  Regulation of interferon-induced protein kinase PKR: modulation of P58IPK inhibitory function by a novel protein, P52rIPK.

Authors:  M Gale; C M Blakely; D A Hopkins; M W Melville; M Wambach; P R Romano; M G Katze
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

4.  Amplifications of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction.

Authors:  G Deng; M Yu; L C Chen; D Moore; W Kurisu; A Kallioniemi; F M Waldman; C Collins; H S Smith
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  The mouse homologs of RELA and MLK3 are located within a 120-kb fragment on chromosome 19.

Authors:  M Fernandes; C Poirier; N J Lassam; C Larsson; J Guénet; P Gaudray; G F Carle
Journal:  Mamm Genome       Date:  1997-07       Impact factor: 2.957

6.  The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1.

Authors:  Joan S Lewis-Wambi; Helen Kim; Ramona Curpan; Ronald Grigg; Mohammed A Sarker; V Craig Jordan
Journal:  Mol Pharmacol       Date:  2011-07-07       Impact factor: 4.436

7.  Organization, chromosomal localization and promoter analysis of the gene encoding human acidic fibroblast growth factor intracellular binding protein.

Authors:  E Kolpakova; E Frengen; T Stokke; S Olsnes
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

8.  Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells.

Authors:  T Kamalati; D Davies; J Titley; M R Crompton
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

9.  Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site.

Authors:  A Schulze; K Zerfass; D Spitkovsky; S Middendorp; J Bergès; K Helin; P Jansen-Dürr; B Henglein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Oncogenic transformation of normal enterocytes by overexpression of cyclin D1.

Authors:  Diana Kazanov; Itzhak Shapira; Marjorie Pick; Olga Kolker; Eliezer Liberman; Varda Deutsch; Loudmilla Strier; Hadas Dvory-Sobol; Talya Kunik; Nadir Arber
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.